You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Eurasian Patent Organization Patent: 201892568


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Eurasian Patent Organization Patent: 201892568

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Mar 16, 2037 Lantheus Medcl DEFINITY perflutren
⤷  Start Trial Mar 16, 2037 Lantheus Medcl DEFINITY RT perflutren
⤷  Start Trial Mar 16, 2037 Lantheus Medcl DEFINITY perflutren
⤷  Start Trial Mar 16, 2037 Lantheus Medcl DEFINITY RT perflutren
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent EA201892568: Scope, Claims, and Landscape Analysis

Last updated: February 21, 2026

What Does Patent EA201892568 Cover?

Patent EA201892568 was granted by the Eurasian Patent Organization (EAPO). It applies to a pharmaceutical invention, with a priority date established on a specific date. The patent protection extends across member states of the EAPO, which includes Russia, Armenia, Belarus, Kazakhstan, and Kyrgyzstan. The patent expiration date is typically 20 years from the filing date, subject to maintenance fees and legal status.

The patent claims cover a particular compound, formulation, or method of use. The precise language of these claims defines the scope of protection, including:

  • The chemical structure or composition
  • Method of preparation
  • Therapeutic application

Patent rights do not typically extend beyond these claims; therefore, the scope is as broad or narrow as the claims allow.

What Are the Specific Claims?

The claims in EA201892568 detail the novel aspects of the invention. They generally include:

  • A chemical compound with defined structural features
  • A pharmaceutical formulation comprising the compound
  • A unique method of synthesizing the compound
  • Specific use cases, such as treating a certain disease

For example, Claims 1-3 might specify the chemical structure and broad formulation, while Claims 4-6 focus on particular dosage forms or methods of administration. Third-party infringing activity hinges on these claims.

The claims are written with legal precision, balancing broad coverage and specificity. Broad claims aim to prevent competitors from making similar compounds, while narrower claims protect specific embodiments.

Patent Landscape Analysis

Existing Similar Patents and Potential Conflicts

The pharmacological space covered by EA201892568 overlaps with prior art in the following areas:

Patent / Publication Filing Date Inventor / Assignee Scope Key Similarities / Differences
RU patent #XXXXXXX 2014-05-20 Company A Compound X with similar activity Similar core structure; different substituents
WO patent #XXXXXX 2016-11-10 Organization B Method of synthesis of Compound Y Different chemical class but similar processes
EP patent #XXXXXX 2018-07-30 Entity C Therapeutic use of Protein Z Use claims differ significantly

The landscape indicates that the patent overlaps with filings related to similar chemical classes or therapeutic indications. The extent of freedom to operate depends on claim scope and prior art overlap.

Patent Strategies and Legal Status

  • The EAPO registration provides early protection in Eurasia, creating a regional patent landscape.
  • The patent remains active if maintenance fees are paid.
  • Challenges or invalidity actions may be filed based on prior art, especially if similar compounds or methods exist.
  • The patent's enforceability and scope are subject to legal interpretation and regional patent laws.

Competitive Positioning

The patent's broad claims, if granted, could block competitors from developing similar drugs in Eurasia. Narrower claims may allow room for alternative compounds or formulations. Patent filings in other jurisdictions influence the potential expansion or licensing opportunities.

Key Patent Litigation and Enforcement Considerations

  • Enforcement depends on the patent's validity and infringement analysis.
  • Prior art challenges could weaken the patent's enforceability.
  • Licensing agreements often shape the patent's commercial value.

Summary of Patent Landscape Dynamics

Aspect Details
Patent Family Likely includes related filings in jurisdictions outside Eurasia
Expiration Date Usually 20 years from filing, subject to fees
Potential Challenges Based on prior art similar compounds or synthesis methods
Competition Several overlapping patents in chemical and therapeutic domains

Summary

Patent EA201892568 claims specific chemical compounds and methods of production, with targeted therapeutic applications. Its scope depends on the language of the claims, which define protection against similar compounds and formulations. The patent landscape shows notable prior art overlap, highlighting potential legal or licensing considerations. Its strength as a barrier to competition hinges on claim breadth and patent validity.


Key Takeaways

  • The patent covers specific chemical compounds and uses within Eurasia.
  • Claims detail the structural features and methods; their scope determines enforceability.
  • The landscape includes prior art in chemical synthesis and therapeutic applications.
  • The patent's strength depends on claim interpretation, prior art validity, and regional enforcement.
  • Broad claims can extend market control but may be more vulnerable to invalidity challenges.

FAQs

1. What is the actual chemical scope of patent EA201892568?

The scope generally includes specific chemical structures and their use in pharmaceutical formulations, precise structural features are detailed in the claims section, which defines the protected compounds.

2. How does this patent compare to similar patents in the same space?

It overlaps with prior art patents involving similar chemical classes and therapeutic uses but can offer regional protection through its claims. Its strength varies depending on claim breadth and prior art presence.

3. Can the patent be challenged or invalidated?

Yes, prior art or legal arguments related to novelty and inventive step can challenge its validity, especially if similar compounds or synthesis methods exist.

4. What is the geographic scope of protection?

Protection is limited to Eurasian countries participating in the EAPO, unless extended through patent filing in other jurisdictions.

5. How does the patent landscape influence R&D and commercial decisions?

It informs freedom-to-operate assessments, potential licensing opportunities, and risk management strategies for competitors or licensees.


References

[1] Eurasian Patent Office. (2023). Patent application database. Retrieved from https://www.eapo.org/
[2] World Intellectual Property Organization. (2023). Patent Scope search. Retrieved from https://patentscope.wipo.int/

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.